Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Articles by Staff Report  -  Page 331
Latest

OCB Bancorp reports strong third quarter

By   /  Wednesday, November 25th, 2015  /  Banking & Finance, Banking Industry, Earnings, Latest news  /  Comments Off on OCB Bancorp reports strong third quarter

The parent company of Ojai Community Bank has increased its net income 52 percent year to date for the nine months ending Sept. 30, according to OCB Bancorp’s third-quarter report. OCB Bancorp, also the parent company of Santa Barbara Community Bank, Ventura Community Bank and Santa Paula Community Bank, increased its total loans by $48 Read More →

Read More →
Latest

Court OKs bids for former Haggen stores in Tri-Counties

By   /  Wednesday, November 25th, 2015  /  Latest news, Top Stories  /  Comments Off on Court OKs bids for former Haggen stores in Tri-Counties

A Delaware bankruptcy court has approved six of the original seven bids for former Haggen stores throughout the Tri-Counties. The Washington-based grocery chain announced on Nov. 25 that the court approved the sale of 47 of its 164 stores. Pending successful deals with landlords, Albertsons will take over its former location at 1500 N. H Read More →

Read More →
Latest

Amgen asks FDA to approve biosimilar drug

By   /  Wednesday, November 25th, 2015  /  Central Coast Health Watch, Latest news, Top Stories  /  Comments Off on Amgen asks FDA to approve biosimilar drug

Amgen submitted an application to the Food and Drug Administration for approval of its biosimilar drug ABP 501 on Nov. 25. ABP 501 is designed as a lower-cost version of Humira, which is approved to treat nine conditions including arthritis, skin disorders and colon inflammation. Humira, made by Chicago-based AbbVie, typically costs $20,000 per year Read More →

Read More →
Latest

Revenues at Santa Barbara’s QAD down for third quarter

By   /  Wednesday, November 25th, 2015  /  Earnings, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Revenues at Santa Barbara’s QAD down for third quarter

Santa Barbara software developer QAD Inc. saw revenues decrease slightly in the third quarter of fiscal year 2016. Revenues at QAD decreased from $74 million to $68 million. Net income for the company was $2.6 million, or 14 cents per share. That missed analyst estimates of 18 cents per share. In recent years, QAD has Read More →

Read More →
Latest

NRG Energy to demolish Mandalay power plant, cooling tower if new plant approved

By   /  Thursday, November 19th, 2015  /  Energy, Latest news, Top Stories, West Ventura County  /  Comments Off on NRG Energy to demolish Mandalay power plant, cooling tower if new plant approved

  NRG Energy updated the application for its new peaker power plant in Oxnard on Nov. 19. In an updated filing with the California Public Utilities Commission, NRG said it would demolish the current power plant and a cooling tower on the site if the new Puente Power Project is approved by the commission. Dave Read More →

Read More →
Latest

Gold Coast Recycling celebrates 25th anniversary

By   /  Thursday, November 19th, 2015  /  Latest news, Top Stories, West Ventura County  /  Comments Off on Gold Coast Recycling celebrates 25th anniversary

  When California passed AB 939 in 1989, the mandatory waste diversion goals looked lofty and unreachable. But Harrison Industries of Ventura stepped up with a unique plan to provide all of its customers in Ventura and Santa Barbara counties with waste bins that allowed them to separate trash and recyclables. Twenty-five years later, Gold Read More →

Read More →
Latest

European regulators approve Amgen cancer drug Kyprolis

By   /  Thursday, November 19th, 2015  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on European regulators approve Amgen cancer drug Kyprolis

Thousand Oaks-based Amgen scored another major victory Nov. 19. European regulators approved experimental drug Kyprolis on Thursday for patients who have received at least one prior treatment for multiple-myeloma. Kyprolis was the cornerstone of Amgen’s $10.4 billion buyout of Onyx Pharmaceuticals in 2013. Multiple-myeloma is a form of blood cancer that forms in plasma cells Read More →

Read More →